Oct 12, 2026 06:02AM
Oct 12, 2026 06:00AM
Oct 6, 2026 06:00AM
Sep 28, 2026 06:01AM
Sep 28, 2026 06:00AM
Sep 24, 2026 06:00AM
Sep 24, 2026 06:00AM MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)
Sep 17, 2026 02:51AM
Sep 8, 2026 06:00AM
Jul 15, 2026 08:03AM
Jul 15, 2026 08:00AM
Jun 30, 2026 08:01AM
Jun 30, 2026 08:00AM
Jun 8, 2026 08:00AM MediciNova receives patent allowance for glioblastoma combination therapy
Jun 8, 2026 08:00AM
May 26, 2026 07:00PM
Apr 27, 2026 07:00PM
Mar 16, 2026 07:00AM
Jan 29, 2026 06:01PM
Jan 29, 2026 06:00PM
Jan 6, 2026 09:00AM 2026 New Year’s Greetings from the CEO
Dec 18, 2025 06:01AM
Dec 18, 2025 06:00AM
Dec 8, 2025 06:00AM
Dec 8, 2025 06:00AM
Nov 18, 2025 06:01AM
Nov 18, 2025 06:00AM
Nov 6, 2025 06:00PM MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awards
Nov 4, 2025 07:00AM
Oct 30, 2025 07:00PM
Oct 6, 2025 08:00AM
Sep 22, 2025 08:03AM
Sep 22, 2025 08:00AM
Sep 16, 2025 08:00AM
Sep 8, 2025 09:02AM MediciNova achieves target enrollment for ALS trial, secures $30M equity line
Sep 8, 2025 09:00AM
Sep 3, 2025 07:00AM
Aug 26, 2025 07:00PM
Jul 31, 2025 07:31PM
Jul 31, 2025 07:30PM
Jul 24, 2025 06:01AM
Jul 24, 2025 06:00AM MediciNova Provides Enrollment Update for Ongoing ALS and Hypertriglyceridemia Clinical Trials
Apr 14, 2025 07:00PM
Apr 8, 2025 07:00PM
Dec 5, 2024 06:00PM
Nov 19, 2024 09:02AM
Nov 19, 2024 09:00AM
Nov 14, 2024 06:00PM
Nov 11, 2024 06:00PM MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis
Oct 23, 2024 07:00PM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All